Volume | 1,578,948 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.1749 | Mínimo Máximo |
|||||
Minimo del Dia | 0.16 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Biolase Inc | BIOL | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.1657 | 0.16 | 0.1749 | 0.1708 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
2,898 | 1,578,948 | US$ 0.1652147 | US$ 260,865 | - | 0.1251 - 9.88 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
12:00:30 | 1 | US$ 0.1623 | USD |
Información Financiera Biolase Inc BIOL
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
367.48k | 2.30M | - | 49.16M | -37.62M | -16.38 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Biolase Inc BIOL
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
17/5/2024 | 05:42 | Edgar (US Regulatory) | Form 8-K - Current report |
13/5/2024 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
06/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
08/3/2024 | 05:31 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
05/3/2024 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
27/2/2024 | 15:14 | Edgar (US Regulatory) | Form 8-K - Current report |
23/2/2024 | 15:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
21/2/2024 | 15:39 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
21/2/2024 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
14/2/2024 | 12:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
Histórico de Datos BIOL
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1709 | 0.1973 | 0.16 | 0.1816684 | 2,517,376 | -0.0086 | -5.03% |
1 Month | 0.15 | 0.20 | 0.146 | 0.1722442 | 2,969,366 | 0.0123 | 8.20% |
3 Months | 0.1349 | 0.257 | 0.1255 | 0.171656 | 4,949,476 | 0.0274 | 20.31% |
6 Months | 1.19 | 1.88 | 0.1251 | 0.1894426 | 3,363,314 | -1.03 | -86.36% |
1 Year | 8.97 | 9.88 | 0.1251 | 3.88 | 3,331,256 | -8.81 | -98.19% |
3 Years | 72.00 | 594.00 | 0.1251 | 28.28 | 2,286,002 | -71.84 | -99.77% |
5 Years | 165.00 | 594.00 | 0.1251 | 62.95 | 4,145,201 | -164.84 | -99.90% |